Invention Grant
US08192386B2 System and method for controlling hematocrit during a therapeutic red blood cell exchange procedure 有权
用于在治疗性红细胞交换程序期间控制血细胞比容的系统和方法

  • Patent Title: System and method for controlling hematocrit during a therapeutic red blood cell exchange procedure
  • Patent Title (中): 用于在治疗性红细胞交换程序期间控制血细胞比容的系统和方法
  • Application No.: US12392239
    Application Date: 2009-02-25
  • Publication No.: US08192386B2
    Publication Date: 2012-06-05
  • Inventor: Kyungyoon Min
  • Applicant: Kyungyoon Min
  • Applicant Address: US IL Lake Zurich
  • Assignee: Fenwal, Inc.
  • Current Assignee: Fenwal, Inc.
  • Current Assignee Address: US IL Lake Zurich
  • Agency: Cook Alex Ltd.
  • Main IPC: A61M37/00
  • IPC: A61M37/00 C02F1/44
System and method for controlling hematocrit during a therapeutic red blood cell exchange procedure
Abstract:
Systems and methods for controlling hematocrit during a blood processing procedure. In one aspect, a system includes a first flow path for flowing whole blood from a patient. A separator communicates with the first flow path for separating at least red blood cells from plasma. Second and third flow paths communicate with the separator for respectively flowing the separated plasma and red blood cells from the separator. A flow controller is associated with the second and third flow paths to control fluid communication between the second and third flow paths and addition of separated plasma to the separated red blood cells. The resulting red blood cells and plasma has a resulting hematocrit. Hematocrit is calculated or sensed in operative association with the third flow path and communicated to the flow controller for controlling the amount of plasma added to the third flow path and the resulting hematocrit.
Information query
Patent Agency Ranking
0/0